Scientists discover how immune cells navigate inflammation, opening drug targets

Researchers identified a molecular switch—an RNA editor called ADAR2—that controls how immune cells move through blood vessel walls during infection and injury. The finding could accelerate development of therapies for inflammatory diseases like sepsis and autoimmune conditions, where controlling immune cell migration is critical to patient outcomes.

Originaltitel: The RNA editor ADAR2 promotes immune cell trafficking by enhancing endothelial responses to interleukin-6 during sterile inflammation